EveryLife Foundation submitted comments to FDA on the Draft Guidance document December 22, 2023 Share this page Comments to inform the Food and Drug Administration on the Draft Guidance document entitled Formal Meetings Between the FDA and Sponsors or Applicants of PDUFA Products Patient-Focused Drug Development (PFDD) FDA User Fees Related Articles Breaking News: The FDA has released the draft goals letter for PDUFA VIII August 13, 2026 The EveryLife Foundation Submits Comments to Support Patient-Focused Drug Development and Medical Innovation July 01, 2026 The EveryLife Foundation Submits Comments in Response to Rep. Auchincloss' Request July 01, 2026 See All News